Articles citing this paper
"Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency
Peter Davis
28(2) pp.171 - 181
17 articles found in Crossref database.
Cost Containment and Efficiency in National Health Systems (2008)
PHARMAC decision-making on new medicines. A case study
Davis Peter
Journal of Primary Health Care. 2022 14(1). p.4
Limits to Neoliberal Reforms in the Health Sector: The Case of Pharmaceutical Management in New Zealand
Dew Kevin, Davis Amy
International Journal of Health Services. 2014 44(1). p.137
Tendering for off-patent outpatient medicines: lessons learned from experiences in Belgium, Denmark and the Netherlands
Vogler Sabine,
Gombocz Margit, Zimmermann Nina
Journal of Pharmaceutical Health Services Research. 2017 8(3). p.147
A SCIENTIFIC STANDARD AND AN AGENCY’S LEGAL INDEPENDENCE: WHICH OF THESE REPUTATION PROTECTION MECHANISMS IS LESS SUSCEPTIBLE TO POLITICAL MOVES?
MAOR MOSHE
Public Administration. 2007 85(4). p.961
How do Governments Steer Health Policy? A Comparison of Canadian and New Zealand Approaches to Cost Control and Primary Health Care Reform
Tenbensel Tim
Journal of Comparative Policy Analysis: Research and Practice. 2008 10(4). p.347
Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following Its 20th Anniversary
Gauld Robin
PharmacoEconomics. 2014 32(10). p.937
The shaping of pharmaceutical governance: the Israeli case
Sax Philip
Israel Journal of Health Policy Research. 2014 3(1).
Centralized drug review processes: Are they fair?
Mitton Craig R.,
McMahon Meghan,
Morgan Steve, Gibson Jennifer
Social Science & Medicine. 2006 63(1). p.200
Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea
Hasan Syed Shahzad,
Kow Chia Siang,
Dawoud Dalia,
Mohamed Omneya,
Baines Darrin, Babar Zaheer-Ud-Din
Value in Health Regional Issues. 2019 18 p.18
New Zealand's Health System: National Policy Goals and Decentralized Service Planning and Delivery
Gauld Robin
The American Heart Hospital Journal. 2007 5(3). p.177
R&D in the Belgian Pharmaceutical Sector
De Doncker Helga
SSRN Electronic Journal. 2006
Public health and the promise of free trade
Woodward Fergus, Woodward Alistair
Australian and New Zealand Journal of Public Health. 2011 35(6). p.504
The Medicare Prescription Drug Plan Formulary
Teagarden J. Russell
Hospital Pharmacy. 2005 40(9). p.822
KEY INFORMANTS’ PERCEPTIONS OF HOW PHARMAC OPERATES IN NEW ZEALAND
Ragupathy Rajan,
Tordoff June,
Norris Pauline, Reith David
International Journal of Technology Assessment in Health Care. 2012 28(4). p.367
“Price Management” and Its Impact on Hospital Pharmaceutical Expenditure and the Availability of Medicines in New Zealand Hospitals
Tordoff June M.,
Norris Pauline T., Reith David M.
Value in Health. 2008 11(7). p.1214
Evaluating New Zealanders’ Values for Drug Coverage Decision Making: Trade-Offs between Treatments for Rare and Common Conditions
Yamoah Linda,
Dragojlovic Nick,
Smith Alesha,
Lynd Larry D., Marra Carlo A.
PharmacoEconomics. 2021 39(1). p.109
